Wedbush Securities’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
Wedbush Securities's TNDM Position: Q3 2024 in Review
Wedbush Securities sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 5,902 shares — an estimated $238K sold.
Wedbush Securities first reported a position in TNDM in Q3 2016 and held it in 16 quarters. The position peaked at $560K in Q3 2018. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.
- Wedbush Securities reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
- Wedbush Securities sold 5,902 Tandem Diabetes Care shares in Q3 2024, an estimated $238K.
- Wedbush Securities first reported a position in Tandem Diabetes Care in Q3 2016 and held it in 16 quarters.
- Wedbush Securities's Tandem Diabetes Care position peaked at $560K in Q3 2018.
- 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.
Based on Wedbush Securities's 13F filing for Q3 2024, filed 8 Nov 2024.